IMTECH Takes Up Sample Testing for COVID-19

IMTECH Takes Up Sample Testing for COVID-19

  • Research Stash
  • News
  • 2.1K

The COVID-19 has posed several challenges to the healthcare sector. The limited number of test kits for COVID-19 is one such challenge. As of now, India has been primarily testing patients with travel history. However, the rate of testing should improve in terms of testing per million population.

To boost its testing capacity, the Council of Scientific and Industrial Research-Institute of Microbial Technology (CSIR-IMTECH) has stepped up to take up COVID-19 sample testing. This is in line with the directives issued by the Principal Scientific Advisor (PSA) to the Government of India and the advisory issued by the Indian Council of Medical Research (ICMR) to operationalize COVID-19 testing by laboratories under CSIR and other labs affiliated to Department of Science and Technology (DST), Department of Biotechnology (DBT) and Department of Atomic Energy (DAE).

“The initiative of ICMR to involve all government-accredited labs is a welcome step and will be a game-changer in the testing of COVID-19 samples. This would increase the testing rate among suspected patients. In the initial phase, IMTECH plans to operationalize capabilities to carry out testing of 50 to 100 samples a day, which can be subsequently ramped up as and when required,” said Dr. Sanjeev Khosla, Director, IMTECH, Chandigarh.

The biosecurity lab has the requisite infrastructure including Biosafety Level (BSL)-3 facility as the labs are advised to take all appropriate biosafety and biosecurity precautions before testing. A newly constructed BSL-2+ virology lab equipped with Reverse Transcription Polymerase Chain Reaction (RT-PCR) equipment has also been established. All the mandatory approvals required for testing of clinical samples have been obtained to operationalize testing at the earliest.

Apart from testing of clinical samples, CSIR-IMTECH is also supporting healthcare professionals by providing Personal Protection Equipment (PPE) to prevent them from contracting any infection while serving patients. The institute is also extending help to the local administration and Red Cross Unit of Chandigarh by providing logistical and infrastructure support. (ISW)

Jyoti Singh

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook.

Rate

The biosecurity lab has the requisite infrastructure including Biosafety Level (BSL)-3 facility as the labs are advised to take all appropriate biosafety and biosecurity precautions before testing. A newly constructed BSL-2+ virology lab equipped with Reverse Transcription Polymerase Chain Reaction (RT-PCR) equipment has also been established. All the mandatory approvals required for testing of clinical samples have been obtained to operationalize testing at the earliest.

Apart from testing of clinical samples, CSIR-IMTECH is also supporting healthcare professionals by providing Personal Protection Equipment (PPE) to prevent them from contracting any infection while serving patients. The institute is also extending help to the local administration and Red Cross Unit of Chandigarh by providing logistical and infrastructure support. (ISW)

Jyoti Singh

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook.

" }
Double Whammy of Groundwater in India

Double Whammy of Groundwater in India

Over-extraction of groundwater is a major environmental challenge in many parts of India. It is not only leading to a rapid decline in groundwater reserves but also contributing to India’s carbon emissions, a new study has warned

  • News
  • 2.6K
Read more
Scientists Gain New Insight into Neurodegenerative Diseases Using Fruit Flies

Scientists Gain New Insight into Neurodegenerative Diseases Using Fruit Flies

A team of scientists from India, Ireland and America have uncovered a novel role of a protein, Ataxin-2, in initiation and progression of neurodegenerative diseases - Amyotrophic Lateral Sclerosis (ALS) and Spinocerebellar Ataxia Type 2 (SCA2).

  • News
  • 3.9K
Read more
Designer Biosensors to Probe the Activation of Important Drug Targets

Designer Biosensors to Probe the Activation of Important Drug Targets

Researchers from IIT Kanpur have engineered antibody-based biosensors in the laboratory using protein-design approaches. These biosensors report the activation of important drug targets, and the approach used in this study also offers new solutions to the long-standing challenge of generating high-quality antibodies for life science research

  • News
  • 1.8K
Read more

Internet is huge! Help us find great content

Newsletter

Never miss a thing! Sign up for our newsletter to stay updated.

About

Research Stash is a curated collection of tools and News for S.T.E.M researchers

Have any questions or want to partner with us? Reach us at hello@researchstash.com

Navigation

Submit